Navigation Links
Anthera Pharmaceuticals to Present at the 2013 Leerink Global Healthcare Conference
Date:2/7/2013

HAYWARD, Calif., Feb. 7, 2013 /PRNewswire/ -- Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH) a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation and autoimmune disorders, today announced Paul F. Truex , Anthera's President and Chief Executive Officer, will present at the 2013 Leerink Global Healthcare Conference in New York, NY on Thursday, February 14, 2013 at approximately 8:00 am Eastern Time.

2013 Leerink Global Healthcare Conference Presentation
Date/Time: Thursday, February 14, at 8:00 am Eastern Time
Location: The Waldorf Astoria New York

About Anthera Pharmaceuticals

Anthera Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing products to treat serious diseases associated with inflammation and autoimmune diseases.

CONTACT: Bianca Nery of Anthera Pharmaceuticals, Inc., bnery@anthera.com or 510.856.5586.


'/>"/>
SOURCE Anthera Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Anthera Pharmaceuticals Announces Departure of Georgina Kilfoil
2. Anthera Pharmaceuticals Announces Completion of Public Offering of Common Stock
3. Anthera Announces Data from the Phase 2b PEARL-SC Study Presented at the 2012 Asian Lupus Summit
4. Anthera Pharmaceuticals to Present at the Piper Jaffray Health Care Conference
5. Anthera Announces Additional Data from the Phase 2b PEARL-SC Presented at the ACR/ARHP 2012 Annual Scientific Meeting
6. Anthera Announces the Phase 2b PEARL-SC Data Has Been Accepted as a Late Breaking Poster Presentation at the ACR/ARHP 2012 Annual Scientific Meeting
7. Anthera Announces the Advancement of Blisibimod into Phase 3 Development for Patients with Systemic Lupus Erythematosus (SLE)
8. Anthera Pharmaceuticals Reports 2012 Second Quarter Financial Results And Provides Clinical Progress Update
9. Anthera Pharmaceuticals Announces Exercise in Full of Over-Allotment Option and Completion of Public Offering of Common Stock
10. Anthera Pharmaceuticals Announces Pricing of Public Offering of Common Stock
11. Anthera Pharmaceuticals Announces Proposed Public Offering of Common Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2017)... -- Stock-Callers.com navigates the Medical Instruments and Supplies ... of non-electronic medical, surgical, dental, and veterinary instruments and apparatus. ... Dickinson and Co. (NYSE: BDX), Antares Pharma Inc. (NASDAQ: ATRS), ... Download the free research reports on these stocks today: ... http://stock-callers.com/registration ...
(Date:3/30/2017)... 2017 The topical drug delivery market ... 2016, growing at a CAGR of 6.4% from 2016 to ... major end-user in market. While North America ... ... tables and 41 figures, 10 Company profiles spread across 144 ...
(Date:3/30/2017)... -- Lannett Company, Inc. (NYSE: LCI ) today ... payment against its existing revolving credit facility. ... million payment we made earlier this year in January, ... interest expense, at current rates" said Arthur Bedrosian ... solid and we continue to generate strong cash flows, ...
Breaking Medicine Technology:
(Date:3/29/2017)... , ... March 29, 2017 , ... In the United ... 300,000 people each year develop other types of metastatic brain tumors(3). Though most meningiomas ... brain(3). As efforts focus on finding more effective treatment options, the San Diego ...
(Date:3/29/2017)... ... March 30, 2017 , ... Youth Futures International (YFI) premiered ... feedback from high school and college students who have participated in the program every ... and YFI is now accepting applications for enrollment. Visit http://www.ghana.yfiexperience.org to ...
(Date:3/29/2017)... ... March 29, 2017 , ... ... or without a referral to new patients from Burnaby, BC. Patients in need ... full mouth reconstruction services, can see the esteemed team at Wall Centre Dental. ...
(Date:3/29/2017)... MINNETONKA, Minn. (PRWEB) , ... March 29, 2017 ... ... of medical office buildings (MOBs) and other outpatient facilities, and who are the ... look exclusively at those questions, Revista and Healthcare Real Estate Insights (HREI) found ...
(Date:3/29/2017)... Ca (PRWEB) , ... March 29, 2017 , ... ... process in many scientific laboratories. The assembly protocols involve many repetitive steps and ... suited for automation, which enables the high-throughput needed, and results in a lower ...
Breaking Medicine News(10 mins):